SITC Resource Library

On October 13, 2021, leading experts from the SITC Urothelial Cancer Immunotherapy Guideline Expert Panel presented "Practical Management Pearls for Immunotherapy for the Treatment of Urothelial Cancer — SITC CPG Webinar." This high-level webinar covered advanced concepts of toxicity management and risk factors drawing from recommendations within the Clinical Practice Guideline(CPG). The recorded webinar and presentation slides are available below.

Webinar Faculty:

• Moderator: Shilpa Gupta, MD — Cleveland Clinic Taussig Cancer Center (Expert Panel Member)
• Neal D. Shore, MD — Carolina Urologic Research Center (Expert Panel Member)
• Petros Grivas, MD — University of Washington (Expert Panel Member)

The webinar discussed:

• nonmuscle-invasive bladder cancer (NMIBC) management
• defining BCG unresponsive disease and planning alternative treatments
• systemic therapy sequencing in urothelial cancers and associated adverse events
• management of severe irAEs
• when to re-challenge disease with immune checkpoint inhibitors (ICI)

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, please visit connected.sitcancer.org, or check out our free CPG mobile app.

The Practical Management Pearls and Case Studies Webinars are part of the Cancer Immunotherapy Clinical Practice Guidelines Advanced Webinar Series supported, in part, by grants from Amgen and Merck & Co., Inc. (as of 9/15/2021).
The SITC Clinical Practice Guidelines are produced and funded solely by SITC. No outside funding is received for the development of the manuscripts.